Pharmacologic evaluation of 3,4-dimethoxyphenylpropenes and 3,4-dimethoxyphenylpropanediols.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004597:Electroshock; D005054:Eugenol / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006018:Glycols / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006591:Hexobarbital / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008297:Male; D008745:Methylation; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects*; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D012640:Seizures / Q000517:prevention & control; D013329:Structure-Activity Relationship; D013331:Strychnine / Q000037:antagonists & inhibitors
D006018:Glycols; D005054:Eugenol; D006591:Hexobarbital; D013331:Strychnine; D010433:Pentylenetetrazole